EKF Diagnostics Holdings plc expected its results for the first half of 2015 to show unaudited revenues of £16.8 million, around the same level as last year, despite not having materially benefited from any tender wins in the current period. Unaudited adjusted EBITDA for the period will be around £0.7 million (in the first half of 2014: £2.2 million). This reduced level of earnings reflects the continuing impact of the investment in its Molecular division.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.45 GBX | -0.76% | -1.67% | +2.53% |
05-15 | Future Metals celebrates state government grant | AN |
05-14 | EKF Diagnostics Holdings Says Q1 Adj EBITDA Shows About 20% Improvement | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.53% | 187M | |
-17.59% | 2.74B | |
-16.53% | 80.66M |
- Stock Market
- Equities
- EKF Stock
- News EKF Diagnostics Holdings plc
- EKF Diagnostics Holdings plc Provides Earnings Guidance for the Six Months Ended June 30, 2015